Chemistry Capability / Capacity Development Analytical Track

提高能力和容量 微生物和化学检测支持 食品防务与食品安全一体化体系 化学学科，能力/能力发展分析轨迹 项目摘要/摘要 俄亥俄农业部(ODA)消费者保护实验室(CPL)建议 将FDA开发的过敏原筛查方法纳入他们的实验室作为 人类食品常规筛查方法。XMAP食品变应原检测方法的建立 (XMAP FADA)试剂盒通过多路分析技术而不是更多进行创新 传统的酶联免疫吸附试验技术；优点包括能够检测多种过敏原 同时，通过蛋白质的交叉反应减少假阳性的可能性 跨越不同的工具包。官方发展援助-CPL制定了购买第一个项目年的计划， 安装和开发方法，最终目标是授权分析师将其用于日常工作 对人类食品的监测以补充国家抽样计划以及 LFFM的人类食品检测分析轨道。作为这一进程的一部分，ODA-CPL将参加 能力测试计划，作为能力测试的一部分，并制定书面标准 纳入实验室质量计划的操作规程。实验室 将更新其实验室信息管理系统，以包括新的测试和成本 将按样本进行分析。ODA-CPL打算继续申请类似的 能力和能力发展项目，因为FDA继续向他们提供假设 Oda-CPL目前的人员、技术和设备以及工作流程与 项目。

Increasing the Capability and Capacity of Microbiological and Chemical Testing to Support an Integrated Food Defense and Food Safety System Chemistry Discipline, Capability / Capacity Development Analytical Track Project Summary / Abstract The Ohio Department of Agriculture (ODA) Consumer Protection Laboratory (CPL) proposes incorporate an allergen screening method developed by the FDA into their laboratory as a routine screening method for human food products. The xMAP Food Allergen Detection Assay (xMAP FADA) kit innovates by working through a multiplex assay technology rather than more conventional ELISA technology; benefits include the ability to test for multiple allergens simultaneously and reduces the potential for a false positive through cross-reactivity of proteins across different kits. ODA-CPL has developed a plan for the first project year to purchase, install and develop the method with the end goal to authorize an analyst on its use for routine surveillance of human food products to supplement the state sampling program as well as LFFM’s human food testing analytical track. As part of the process, ODA-CPL will enroll in a proficiency testing scheme as part of its test of competency and develop written standard operating procedures for incorporation into the laboratory’s quality program. The laboratory will update its laboratory information management system to include the new test and a cost analysis per sample will be performed. ODA-CPL intends to continue applying for similar capability and capacity development projects as the FDA continues to offer them assuming ODA-CPL’s current personnel, technology and equipment and workflow is compatible with the project.